Risk determination of developing brain metastasis (Ref. TEC0027)
We have developed a method for determining the risk of developing brain metastasis in a subject diagnosed with a breast tumor. The right of this technology had been already assigned. Key facts of our technology:
- Saving costs and adverse events on patients not suitable for the current therapies.
- The cost of based-on-arrays kits are decreasing.
- Positive Patent Search Report.
TEC0027 / P0011